about
Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancerGenetic associations with sporadic neuroendocrine tumor riskA Large-scale genetic association study of esophageal adenocarcinoma riskGenetic association analysis using sibship data: a multilevel model approach.Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma riskAssociation between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma.Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study.Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database.Prognostic significance of MTOR pathway component expression in neuroendocrine tumors.Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors.Genetic susceptibility in familial melanoma from northeastern Italy.CYP1A1 and CYP1B1 genotypes, haplotypes, and TCDD-induced gene expression in subjects from Seveso, Italy.MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls.Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study.A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics GroupGenome-wide search for CLN2, the gene causing late-infantile neuronal ceroid-lipofuscinosis (LNCL)MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean populationQuality Metrics and Health Care Utilization for Adult Patients with Sickle Cell Disease
P50
Q23918557-59CE53B0-9AF5-4451-88C0-CEBF7D6F64D2Q23918559-3C4C06A6-F99B-4CB0-9560-9AF4025C4493Q24626024-13296F5B-29BA-4428-BF3C-2822EF0A0248Q34152688-1D6CF494-B159-4566-8C68-8BB5EBF6F0ACQ34734104-F59FB7C6-BC25-4F79-B451-E5A5F557564DQ34763711-8CBD2ABD-A5F3-413E-8BEB-34195F7F50ACQ35353824-64CCD193-B97F-43CF-A646-694FA2BF539AQ35638655-5D3ACC70-13F1-44B6-929F-280F83FD4E88Q37085554-82116A7B-2788-496F-AD9D-808C4B1F2DEAQ37165103-459FB40E-E4F1-45A6-BF8D-B8FE63A98468Q37175515-E024FAB1-2F60-4364-B5FE-B034A1F9AD0DQ40540183-9BC5E984-D103-41EB-9C25-008635D7FF20Q42319246-42C2005B-A5B3-42AC-BDC4-193C5324EFCAQ43073623-B2118579-BC5F-4AED-A3EE-24AE957814D4Q45185406-1E0E2D2E-DEAE-40B6-8238-FD0DB591BDBEQ46119303-10D5280B-2756-41DF-A95C-F98A400C1722Q47722867-20201CFB-A0D6-473D-AA43-F69E5B44D97CQ71230101-AA9E9C9D-48F9-4289-8F0A-2A446C6D65C2Q72043013-5E01DB3F-E39E-42D9-B9DC-53B607E97F33Q81926997-664DA2DF-FB5A-4040-AAA9-0A6CC4141166Q91059395-853BE36F-DB31-462E-9030-1CD3DB97AA94
P50
description
researcher ORCID ID = 0000-0002-9497-2585
@en
wetenschapper
@nl
name
Monica Ter-Minassian
@ast
Monica Ter-Minassian
@en
Monica Ter-Minassian
@es
Monica Ter-Minassian
@nl
type
label
Monica Ter-Minassian
@ast
Monica Ter-Minassian
@en
Monica Ter-Minassian
@es
Monica Ter-Minassian
@nl
prefLabel
Monica Ter-Minassian
@ast
Monica Ter-Minassian
@en
Monica Ter-Minassian
@es
Monica Ter-Minassian
@nl
P106
P1153
14631351900
P31
P496
0000-0002-9497-2585